Heron Financial Statements From 2010 to 2024

HRTX Stock  USD 1.06  0.06  5.36%   
Heron Therapeuti financial statements provide useful quarterly and yearly information to potential Heron Therapeuti investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Heron Therapeuti financial statements helps investors assess Heron Therapeuti's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Heron Therapeuti's valuation are summarized below:
Gross Profit
-50.5 M
Profit Margin
(0.20)
Market Capitalization
170.3 M
Enterprise Value Revenue
2.0162
Revenue
137.7 M
We have found one hundred twenty available fundamental trends for Heron Therapeuti, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Heron Therapeuti regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 849.6 M in 2024. Enterprise Value is likely to rise to about 914.8 M in 2024

Heron Therapeuti Total Revenue

133.4 Million

Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Heron Therapeuti Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets233.6 M222.5 M202 M
Slightly volatile
Short and Long Term Debt Total188.6 M179.6 M55 M
Slightly volatile
Other Current Liabilities73.8 M70.3 M42.4 M
Slightly volatile
Total Current Liabilities83.7 M79.7 M53.3 M
Slightly volatile
Property Plant And Equipment Net26.9 M25.6 M15.3 M
Slightly volatile
Cash27.8 M28.7 M55.8 M
Very volatile
Non Current Assets Total35.4 M33.7 M18.8 M
Slightly volatile
Non Currrent Assets Other8.5 M8.1 M3.5 M
Slightly volatile
Cash And Short Term Investments60.9 M80.4 M126.8 M
Slightly volatile
Net Receivables63.1 M60.1 M26.8 M
Slightly volatile
Common Stock Shares Outstanding145 M138.1 M61.5 M
Slightly volatile
Liabilities And Stockholders Equity233.6 M222.5 M202 M
Slightly volatile
Other Stockholder EquityB1.9 BB
Slightly volatile
Total Liabilities269.3 M256.5 M103.5 M
Slightly volatile
Property Plant And Equipment Gross44.8 M42.6 M17.6 M
Slightly volatile
Total Current Assets198.2 M188.8 M183.2 M
Slightly volatile
Short Term DebtM6.2 M5.5 M
Slightly volatile
Other Current Assets5.5 M6.1 M9.6 M
Slightly volatile
Accounts Payable3.2 M3.2 M4.8 M
Pretty Stable
Common Stock Total Equity658 K1.2 M908.3 K
Pretty Stable
Common Stock1.6 M1.5 MM
Very volatile
Other Liabilities263.3 K277.1 K20.2 M
Slightly volatile
Other Assets19 M18.1 M5.9 M
Slightly volatile
Property Plant Equipment36 M34.3 M14.3 M
Slightly volatile
Current Deferred Revenue3.3 M3.2 M1.8 M
Slightly volatile
Capital SurpluseB1.9 BB
Slightly volatile
Short and Long Term Debt8.3 M8.1 MM
Slightly volatile
Long Term Debt Total109.5 M171.4 M101.7 M
Slightly volatile
Non Current Liabilities Other206.1 K216.9 K27.3 M
Slightly volatile
Net Invested Capital196.2 M139.8 M202.1 M
Pretty Stable
Net Working Capital170.3 M109.1 M168.9 M
Pretty Stable
Capital Stock1.2 M1.5 M915 K
Slightly volatile
Capital Lease ObligationsM5.9 M12.8 M
Slightly volatile

Heron Therapeuti Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And AmortizationM2.9 M1.6 M
Slightly volatile
Other Operating Expenses249.5 M237.7 M178.2 M
Slightly volatile
Cost Of Revenue68.4 M65.1 M33.7 M
Slightly volatile
Total Operating Expenses181.2 M172.6 M153.9 M
Slightly volatile
Research Development48.9 M55.9 M83 M
Slightly volatile
Selling General Administrative51.5 M49 M28.9 M
Slightly volatile
Selling And Marketing Expenses64.4 M67.6 M45.7 M
Slightly volatile
Interest Income2.6 M3.4 M2.8 M
Pretty Stable
Reconciled Depreciation2.6 MMM
Slightly volatile

Heron Therapeuti Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow27.8 M15.4 M53.4 M
Slightly volatile
DepreciationM2.9 M1.6 M
Slightly volatile
Capital Expenditures1.8 M1.5 M2.9 M
Slightly volatile
Total Cash From Financing Activities51.5 M54.1 M105.4 M
Pretty Stable
End Period Cash Flow28.5 M28.7 M54.9 M
Very volatile
Stock Based Compensation24.7 M32.9 M25.4 M
Slightly volatile
Sale Purchase Of Stock7.7 M8.1 M79.7 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.761.8484141
Slightly volatile
Days Sales Outstanding110173345
Slightly volatile
Stock Based Compensation To Revenue0.250.25867.4134
Slightly volatile
Capex To Depreciation0.510.53292.4151
Slightly volatile
EV To Sales2.883.0366149
Slightly volatile
Inventory Turnover2.721.54610.8635
Slightly volatile
Days Of Inventory On Hand22423622.5 K
Slightly volatile
Payables Turnover21.120.094115.1143
Slightly volatile
Sales General And Administrative To Revenue0.370.38586.2037
Slightly volatile
Average Inventory70.2 K73.9 K216.7 K
Slightly volatile
Research And Ddevelopement To Revenue0.420.4428.6032
Slightly volatile
Capex To Revenue0.01160.01220.9135
Slightly volatile
Cash Per Share0.550.582112.3326
Slightly volatile
Days Payables Outstanding17.2618.1645K
Very volatile
Intangibles To Total Assets0.0250.04980.0509
Very volatile
Current Ratio2.252.3696.1061
Slightly volatile
Receivables Turnover2.012.11261.5389
Slightly volatile
Graham Number2.02.104533.5669
Slightly volatile
Capex Per Share0.01060.01120.4489
Slightly volatile
Revenue Per Share0.870.91971.601
Slightly volatile
Interest Debt Per Share1.241.30812.5302
Slightly volatile
Debt To Assets0.830.79470.2602
Slightly volatile
Operating Cycle38840922.8 K
Slightly volatile
Days Of Payables Outstanding17.2618.1645K
Very volatile
Ebt Per Ebit0.740.99950.9831
Pretty Stable
Long Term Debt To Capitalization1.311.2431.1564
Pretty Stable
Total Debt To Capitalization1.31.23780.418
Slightly volatile
Quick Ratio1.751.84055.8595
Slightly volatile
Net Income Per E B T0.920.850.9626
Slightly volatile
Cash Ratio0.340.35994.398
Slightly volatile
Days Of Inventory Outstanding22423622.5 K
Slightly volatile
Days Of Sales Outstanding110173345
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.02631.0574
Very volatile
Fixed Asset Turnover5.214.96192.3794
Slightly volatile
Debt Ratio0.830.79470.2602
Slightly volatile
Price Sales Ratio1.761.8484141
Slightly volatile
Asset Turnover0.40.5710.1817
Slightly volatile
Gross Profit Margin0.510.48750.7481
Slightly volatile

Heron Therapeuti Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap849.6 M809.1 M805.9 M
Slightly volatile
Enterprise Value914.8 M871.2 M789.8 M
Slightly volatile

Heron Fundamental Market Drivers

Cash And Short Term Investments80.4 M

Heron Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.2 M3.3 M
Total Revenue127 M133.4 M
Cost Of Revenue65.1 M68.4 M
Stock Based Compensation To Revenue 0.26  0.25 
Sales General And Administrative To Revenue 0.39  0.37 
Research And Ddevelopement To Revenue 0.44  0.42 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.92  0.87 
Ebit Per Revenue(0.87)(0.91)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.